The long term goal of this proposal is to elucidate the molecular mechanisms whereby the IGF signaling axis contributes to the intiation and progression of prostate cancer in an autochthonous model system. To this end, three specific aims are proposed: 1) To test the hypothesis that expression of IGF-I by the prostate gland facilitates the progression of prostate cancer; 2) To test the hypothesis that a correlation exists between the level of serum IGF-I and the rate of initiation and/or progression of prostate cancer; and 3) To test the hypothesis that prostate specific abrogation of the IGF-I / IGF1R signaling axis inhibits the initiation and/or progression of prostate cancer. To accomplish the first specific aim, the consequence of prostate specific IGF-I transgene expression win be characterized with respect to time to palpable tumor, tumor grade and metastatic incidence in transgenic mice carrying a probasin (PB) directed DES-IGF-I transgene and in [PB-DES IGF-I X TRAMP]F1 mice. To accomplish the second specific aim, the consequence of elevated systemic IGF-I levels will be characterized with respect to time to palpable tumor, tumor grade and metastatic incidence in MT-GHRH transgenic mice, [MT-GHRH X TRAMP]F1, C3H mice and [TRAMP X C3H]F1 mice. To accomplish the third specific aim, the consequence of Cre/LoxP mediated prostate-specific ablation of IGF-I and IGF1R expression will be characterized with respect to time to palpable tumor, tumor grade and metastatic incidence in [TRAMP:LoxP-IGF-I:Cre] and [TRAMP:loxP-IGF1R:Cre] mice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA082807-06
Application #
7069432
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Mohla, Suresh
Project Start
1999-07-01
Project End
2006-03-31
Budget Start
2004-04-01
Budget End
2006-03-31
Support Year
6
Fiscal Year
2003
Total Cost
$244,600
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Sutherland, Brent W; Knoblaugh, Sue E; Kaplan-Lefko, Paula J et al. (2008) Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Cancer Res 68:3495-504
Kaplan-Lefko, P J; Sutherland, B W; Evangelou, A I et al. (2008) Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis. Oncogene 27:2868-76
Goel, Hira Lal; Breen, Michael; Zhang, Jianzhong et al. (2005) beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res 65:6692-700
Huss, Wendy J; Barrios, Roberto J; Foster, Barbara A et al. (2003) Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression. Prostate 54:8-16